Category:
Chiral Intermediates
CAS NO:
152459-95-5
Standard:
In-house Standards,
White white crystalline powder
Gleevec (Imatinib) is a targeted small-molecule inhibitor developed for oncology. Its core synthesis involves multi-step organic reactions yielding C29H31N7O (CAS: 152459-13-3). This compound selectively blocks BCR-ABL tyrosine kinase.
Strictly contraindicated in patients with severe hypersensitivity. Requires storage below 25°C in dry conditions. Clinical use mandates monitoring for hepatotoxicity, fluid retention, and cardiac function due to potential adverse events.